• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    MeiraGTx Holdings plc - Ordinary Shares (NQ:MGTX)

    7.615 +0.165 (+2.21%)
    Streaming Delayed Price Updated: 12:33 PM EST, Feb 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about MeiraGTx Holdings plc - Ordinary Shares

    < Previous 1 2 3 4 Next >
    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
    From BioMedWire
    Via GlobeNewswire
    MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? ↗
    Via Stocktwits
    News headline image
    The Biotech Tug-of-War: Is Kiora Pharmaceuticals Positioned to Ride the 2025 Commodity Wave?
    As of December 18, 2025, the financial landscape is defined by a stark divergence in the commodities market, creating a complex environment for clinical-stage biotechnology firms. While gold prices... 
    Via MarketMinute
    Topics Derivatives Economy Intellectual Property
    News headline image
    MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration ↗
    MeiraGTx shares rise after signing a $475 million deal with Eli Lilly for a gene therapy program restoring vision in children with LCA4. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
    Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms 
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Sales Jump 1,133 Percent ↗
    Via The Motley Fool
    News headline image
    MeiraGTx Reports Second Quarter 2025 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
     
    Via Benzinga
    News headline image
    MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
    Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell Therapy 
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Reports First Quarter 2025 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps. 
    Via Chartmill
    News headline image
    Crude Oil Falls 1%; Dollar General Posts Upbeat Sales ↗
     
    Via Benzinga
    News headline image
    G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars ↗
    MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments. 
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations
    MeiraGTx has recently received Rare Pediatric Disease Designation (RPDD) for four inherited retinal diseases (IRDs) reflecting the transformative therapeutic potential of the Company’s proprietary... 
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good ↗
    SoFi Technologies, Inc. is good, Jim Cramer said. It reported third-quarter adjusted sales of $689.445 million, according to Benzinga Pro. 
    Via Benzinga
    News headline image
    MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
    Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms 
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results ↗
     
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.